期刊文献+

老年冠心病患者支架内再狭窄的相关因素分析 被引量:5

Analysis of risk factors for in-stent stenosis in elderly patients with coronary heart disease
原文传递
导出
摘要 目的探讨冠心病老年患者经皮冠状动脉介入术(PCI)后发生支架内再狭窄(ISR)的危险因素。方法选取我院住院行PCI术老年患者418例,年龄60~79岁,平均(71.3±8.9)岁,男性262例,女性156例。收集所有患者可能的PCI术后ISR危险因素进行统计学分析。结果PCI后1年复查,418例中ISR组104例(24.9%)、非ISR组314例(75.1%)。Logistic回归分析结果显示,年龄、性别与ISR发生率无相关性(P〉0.05);体质指数(OR=9.54,95%CI:6.542~32.154,P=0.002)和吸烟(OR=26.01,95%CI:5.532~122.238,P=0.000)、高血压(OR=15.72,95%CI:3.24076.026,P=0.001)、糖尿病(OR=11.98,95%CI:2.667~53.835,P=0.001)、高脂血症史(OR=8.98,95%CI:2.164~37.283,P=0.003)及锻炼时间(OR=5.63,8,95%CI:2.004~25.385,P=0.013)与术后ISR呈正相关。结论控制吸烟、高血压、糖尿病、高脂血症等危险因素,适当运动、控制体质量可防止老年患者PCI后的ISR。 Objective To explore the risk factors for in-stent stenosis (ISR) in coronary artery disease in elderly patients undergoing postoperative percutaneous coronary intervention (PCI). Methods We chose 418 cases undergoing PCI in our hospital. There were 263 males and 156 females, aged from 60 to 79 years, average (71.3 ± 8.9)years in this study. Under the same conditions of treatment strategies, we collected all possible risk factors for ISR in patients undergoing postoperative PCI, and statistics were analyzed. Results All patients were rechecked at 1 year after PCI. 104 cases (24.9%) occurred ISR, and 314 cases (75.1%) were diagnosed without ISR. Multiple logistic analysis showed that, and sex had little effect on 1SR incidence (P〉0.05). Body mass index(OR=9. 54,95% CI:6. 542-32. 154, P=0. 002), smoking history(OR= 26.01,95% CI:5. 532-122. 238, P= 0. 000), hypertension(OR= 15.72,95% CI: 3. 240-76. 026, P=0. 001), diabetes mellitus( OR= 11. 98,95%CI2. 667-53. 835, P= 0. 001) , history of high cholesterol( OR= 8. 98,8,95%0CI2.164 37. 283, P=0. 003 ), exercise time ( OR = 5. 63,8,95 % CI2. 004 - 25. 385, P = 0. 013 ) had positive correlations with ISR incidence . Conclusions Effective control of risk factors including smoking, hypertension, diabetes, high cholesterol, proper exercise, and weight control can help prevent the development of ISR in elderly patients with postoperative PCI.
作者 于辉 赵阳
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2014年第6期591-593,共3页 Chinese Journal of Geriatrics
关键词 支架 冠状动脉再狭窄 危险因素 Stents Coronary stenosis Risk factors
  • 相关文献

参考文献12

  • 1Meliga E, De Benedictis M, Gagnor A, et al. New drug-eluting stent implantation for recalcitrant in- stent restenosis treated with drug eluting stents, the Stent-in-Stent Cube ( SIS3 ) registry [J]. J Invasive Cardiol, 2011, 23:365-368.
  • 2Davies A, Scott A. Acute coronary syndromes[J]. Starting to Read ECGs, 2014, 147-159.
  • 3Van Tiel CM,Bonta PI, Rittersma SZ, et al. p27kipl- 838C > A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kipl promoter activity[J]. Circulation, 2009, 120:669-676.
  • 4Kang SJ, in-stent Mintz GS, Park DW, et al. Mechanisms of restenosis after drug-eluting inpalntation: intravascular ultrasound analysis Circ Cardiovasc Interv, 2011, 4:9-14.
  • 5stent EJ]. Wilson WM1, Walsh S, Hanratty C, et al. A novel approach to the management of occlusive in-stent restenosis (ISR) . EuroIntervention, 2014, 20: 1285-1293.
  • 6Ong PI, Athanasiadis A, vasomotor abnormalities Perne A, et al. Coronary in patients with stable angina after successful stent implantation but without in-stent restenosis[J]. Clin Res Cardiol, 2014, 103: 11-19.
  • 7Harle T, Zeymer U, Sehwarz AK, et al. Use of drug-eluting stents in acute myocardial infarction with persistent ST-segment elevation: results of the ALKK PCI-registry. Clin Res Cardiol, 2014, 103: 373 -380.
  • 8Richardt G, Leschke M, Abdel-Wahab M, et al. Clinical outcomes of the resolute zotarolimus-eluting stent in patients with in-stent restenosis.. 2-year results from a pooled analysis[J]. JACC Cardiovasc Interv, 2013, 6:905 -913.
  • 9黄猛珣,侯勇,王联发.肾素血管紧张素系统与支架内再狭窄[J].中华老年医学杂志,2013,32(3):350-352. 被引量:3
  • 10Kigawa T, Matsumaru Y, Hayakawa M, et al. Cilostazol reduces restenosis after carotid artery stenting[J]. J Vasc Surg, 2010,51 : 51-56.

二级参考文献32

  • 1王育林,赵欣,闫继峰,杨向军,刘志华.阿托伐他汀对家兔动脉粥样硬化斑块中基质金属蛋白酶的影响[J].中华老年医学杂志,2006,25(9):683-686. 被引量:3
  • 2Yan JC, Wu ZG, Kong XT, et al. Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndromes. Acta Pharmacol Sin, 2007, 25: 251-256.
  • 3White AJ, Duffy SJ, Walton AS, et al. Matrix metalloproteinase-3 and coronary remodeling : implications for unstable coronary disease. Cardiovascular Research, 2007, 75:813-820.
  • 4Kaden JJ, Dempfle CE, Sueselbeck T, et al. Time-dependent changes in the plasma concentration of matrix metalloproteinase-9 after acute myocardial infarction. Cardiology, 2003, 99: 140- 144.
  • 5Lofus IM, Naylor AR, Goodall S, et al. Increased matrix metalloproteinase 9 activity in unstable carotid plaque: a potential role in acute plaque disruption. Stroke, 2000, 31:40- 47.
  • 6Meng X, Mavromatis K, Galis ZS. Mechanical stretching of human saphenous vein grafts induces expression and activation of matrix-degrading enzymes associated with vascular tissue injury and repair. Exp Mol Pathol, 1999, 66;227-237.
  • 7Cedro K,Radomski A, Radomski MW, et al. Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina. A preliminary study. Intern J Cardiology, 2003, 92: 177-180.
  • 8Sundstrom J,Evans JC, Benjamin EJ, et al. Relation of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures : the Framingham Heart Study. Eur Heart J, 2004, 25: 1509-1516.
  • 9Shi Y,Patel S, Niculescu R, et al. Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler. Thromb Vase Biol,1999,19:1150-1155.
  • 10Park SW, Lee CW,Kim HS,et al. Effects of cilostazol on angiographic restenosis alter coronary stent placement. Am J Cardiol, 2000,86 : 499-503.

共引文献3

同被引文献40

  • 1吴兆苏,霍勇,王文,赵连友,朱鼎良.中国高血压患者教育指南[J].中国医学前沿杂志(电子版),2014,6(3):78-109. 被引量:91
  • 2Serruys PW, Silber S, Garg S, et al. Comparison of zo- tarolimus - eluting and everolimus- eluting coronary stents[J]. N Eng J Med,2010,363 : 136 - 146.
  • 3Kuwano T, M iura S, Shirai K,et al. Serum levels of bilirubin as an independent predictor of coronary in- stent restenosis: a new look at an old molecule[J]. J Atheroscler Thromb, 2011,18 : 574 - 583.
  • 4Sato T,Ono T, Morimoto Y,et al. Differences in clini- cal and angiographic outcomes with different drug- e- luting stents in Japanese patients with and without di- abetes mellitus[J]. J Cardiol,2012,60 : 361 - 366.
  • 5Banning AP,Baumbach A,Blackman D,et al.Percutaneous coronary intervention in the UK:recommendations for good practice2015[J].Heart,2015,101(Suppl 3):1-13.
  • 6Byrne RA,Joner M,Kastrati A.Stent thrombosis and restenosis:what have we learned and where are we going?The Andreas Grüntzig Lecture ESC 2014[J].Eur Heart J,2015,36(47):3320-3331.
  • 7Indermuehle A,Bahl R,Lansky AJ,et al.Drug-eluting balloon angioplasty for in-stent restenosis:a systematic review and meta-analysis of randomised controlled trials[J].Heart,2013,99(5):327-333.
  • 8Kang SJ,Mintz GS,Park DW,et al.Mechanisms of in stent restenosis after drug-eluting stent implantation:intravascular ultrasound analysis[J].Circ Cardiovasc Interv,2011,4(1):9-14.
  • 9De Caterina AR,Cuculi F,Banning AP.Incidence,predictors and management of left main coronary artery stent restenosis:a comprehensive review in the era of drug-eluting stents[J].Euro Intervention,2013,8(11):1326-1334.
  • 10Hu RT,Liu J,Zhou Y,et al.Association of smoking with restenosis and major adverse cardiac events after coronary stenting:A meta-analysis[J].Pak J Med Sci,2015,31(4):1002-1008.

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部